{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:36:49Z","timestamp":1781105809357,"version":"3.54.1"},"reference-count":39,"publisher":"National Academy of Sciences","issue":"48","license":[{"start":{"date-parts":[[2016,5,16]],"date-time":"2016-05-16T00:00:00Z","timestamp":1463356800000},"content-version":"vor","delay-in-days":182,"URL":"http:\/\/www.pnas.org\/site\/misc\/userlicense.xhtml"}],"funder":[{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI099125"],"award-info":[{"award-number":["R01 AI099125"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"HHS | NIH | National Heart, Lung and Blood Institute","doi-asserted-by":"crossref","award":["R25 HL096365"],"award-info":[{"award-number":["R25 HL096365"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>Factor H binding protein (FHbp) is a component of two vaccines recently licensed for prevention of sepsis and meningitis caused by meningococci. FHbp is antigenically variable, and certain sequence variants have low thermal stability. Two amino acid substitutions stabilized a less stable FHbp variant by 21 \u00b0C, and the high-resolution crystal structure of the stabilized FHbp antigen showed that the two new residues mediated multiple electrostatic interactions. The two substitutions increased the affinity for monoclonal antibodies specific for different regions of FHbp and increased binding to the mutant expressed on the surface of meningococci. The stabilized FHbp antigen has the potential to improve the immunogenicity of meningococcal vaccines containing recombinant FHbp or native outer membrane vesicles.<\/jats:p>","DOI":"10.1073\/pnas.1507829112","type":"journal-article","created":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T22:03:41Z","timestamp":1447711421000},"page":"14823-14828","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":19,"title":["A meningococcal vaccine antigen engineered to increase thermal stability and stabilize protective epitopes"],"prefix":"10.1073","volume":"112","author":[{"given":"Monica","family":"Konar","sequence":"first","affiliation":[{"name":"Center for Immunobiology and Vaccine Development, Children\u2019s Hospital Oakland Research Institute, University of California San Francisco Benioff Children\u2019s Hospital Oakland, Oakland, CA 94609"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Pajon","sequence":"additional","affiliation":[{"name":"Center for Immunobiology and Vaccine Development, Children\u2019s Hospital Oakland Research Institute, University of California San Francisco Benioff Children\u2019s Hospital Oakland, Oakland, CA 94609"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Beernink","sequence":"additional","affiliation":[{"name":"Center for Immunobiology and Vaccine Development, Children\u2019s Hospital Oakland Research Institute, University of California San Francisco Benioff Children\u2019s Hospital Oakland, Oakland, CA 94609"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2015,11,16]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance","volume":"177","author":"Madico G","year":"2006","unstructured":"G Madico, , The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol 177, 501\u2013510 (2006).","journal-title":"J Immunol"},{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1099\/mic.0.027995-0","article-title":"Variation of the factor H-binding protein of Neisseria meningitidis","volume":"155","author":"Brehony C","year":"2009","unstructured":"C Brehony, DJ Wilson, MC Maiden, Variation of the factor H-binding protein of Neisseria meningitidis. Microbiology 155, 4155\u20134169 (2009).","journal-title":"Microbiology"},{"key":"e_1_3_4_3_2","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher LD","year":"2004","unstructured":"LD Fletcher, , Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infect Immun 72, 2088\u20132100 (2004).","journal-title":"Infect Immun"},{"key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani V","year":"2003","unstructured":"V Masignani, , Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J Exp Med 197, 789\u2013799 (2003).","journal-title":"J Exp Med"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease","volume":"28","author":"Jiang HQ","year":"2010","unstructured":"HQ Jiang, , Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease. Vaccine 28, 6086\u20136093 (2010).","journal-title":"Vaccine"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.vaccine.2009.12.027","article-title":"Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates","volume":"28","author":"Pajon R","year":"2010","unstructured":"R Pajon, PT Beernink, LH Harrison, DM Granoff, Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates. Vaccine 28, 2122\u20132129 (2010).","journal-title":"Vaccine"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/656741","article-title":"Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy","volume":"51","author":"Findlow J","year":"2010","unstructured":"J Findlow, , Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy. Clin Infect Dis 51, 1127\u20131137 (2010).","journal-title":"Clin Infect Dis"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/INF.0b013e3181f59f6d","article-title":"Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: A randomized comparative trial","volume":"29","author":"Snape MD","year":"2010","unstructured":"MD Snape, , Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: A randomized comparative trial. Pediatr Infect Dis J 29, e71\u2013e79 (2010).","journal-title":"Pediatr Infect Dis J"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1128\/IAI.00033-08","article-title":"Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines","volume":"76","author":"Beernink PT","year":"2008","unstructured":"PT Beernink, DM Granoff, Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines. Infect Immun 76, 2568\u20132575 (2008).","journal-title":"Infect Immun"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"91ra62","DOI":"10.1126\/scitranslmed.3002234","article-title":"Rational design of a meningococcal antigen inducing broad protective immunity","volume":"3","author":"Scarselli M","year":"2011","unstructured":"M Scarselli, , Rational design of a meningococcal antigen inducing broad protective immunity. Sci Transl Med 3, 91ra62 (2011).","journal-title":"Sci Transl Med"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1073\/pnas.1222845110","article-title":"Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen","volume":"110","author":"Malito E","year":"2013","unstructured":"E Malito, , Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen. Proc Natl Acad Sci USA 110, 3304\u20133309 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1086\/600141","article-title":"Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis","volume":"200","author":"Murphy E","year":"2009","unstructured":"E Murphy, , Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis. J Infect Dis 200, 379\u2013389 (2009).","journal-title":"J Infect Dis"},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1016\/j.vaccine.2011.04.092","article-title":"Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States","volume":"29","author":"Wang X","year":"2011","unstructured":"X Wang, , Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States. Vaccine 29, 4739\u20134744 (2011).","journal-title":"Vaccine"},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1371\/journal.pntd.0001302","article-title":"Meningococcal factor H binding proteins in epidemic strains from Africa: Implications for vaccine development","volume":"5","author":"Pajon R","year":"2011","unstructured":"R Pajon, AM Fergus, O Koeberling, DA Caugant, DM Granoff, Meningococcal factor H binding proteins in epidemic strains from Africa: Implications for vaccine development. PLoS Negl Trop Dis 5, e1302 (2011).","journal-title":"PLoS Negl Trop Dis"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"e1002981","DOI":"10.1371\/journal.ppat.1002981","article-title":"Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules","volume":"8","author":"Johnson S","year":"2012","unstructured":"S Johnson, , Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules. PLoS Pathog 8, e1002981 (2012).","journal-title":"PLoS Pathog"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1016\/j.vaccine.2013.08.099","article-title":"Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice","volume":"31","author":"Rossi R","year":"2013","unstructured":"R Rossi, DM Granoff, PT Beernink, Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice. Vaccine 31, 5451\u20135457 (2013).","journal-title":"Vaccine"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1074\/jbc.M808831200","article-title":"Structural basis for the immunogenic properties of the meningococcal vaccine candidate LP2086","volume":"284","author":"Mascioni A","year":"2009","unstructured":"A Mascioni, , Structural basis for the immunogenic properties of the meningococcal vaccine candidate LP2086. J Biol Chem 284, 8738\u20138746 (2009).","journal-title":"J Biol Chem"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1128\/CVI.00103-10","article-title":"Impaired immunogenicity of a meningococcal factor H-binding protein vaccine engineered to eliminate factor H binding","volume":"17","author":"Beernink PT","year":"2010","unstructured":"PT Beernink, J Shaughnessy, S Ram, DM Granoff, Impaired immunogenicity of a meningococcal factor H-binding protein vaccine engineered to eliminate factor H binding. Clin Vaccine Immunol 17, 1074\u20131078 (2010).","journal-title":"Clin Vaccine Immunol"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1107\/S1744309111006154","article-title":"Structure of the uncomplexed Neisseria meningitidis factor H-binding protein fHbp (rLP2086)","volume":"67","author":"Cendron L","year":"2011","unstructured":"L Cendron, D Veggi, E Girardi, G Zanotti, Structure of the uncomplexed Neisseria meningitidis factor H-binding protein fHbp (rLP2086). Acta Crystallogr Sect F Struct Biol Cryst Commun 67, 531\u2013535 (2011).","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1086\/597806","article-title":"Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa","volume":"199","author":"Beernink PT","year":"2009","unstructured":"PT Beernink, DA Caugant, JA Welsch, O Koeberling, DM Granoff, Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa. J Infect Dis 199, 1360\u20131368 (2009).","journal-title":"J Infect Dis"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1128\/IAI.00103-12","article-title":"Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor H","volume":"80","author":"Pajon R","year":"2012","unstructured":"R Pajon, PT Beernink, DM Granoff, Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor H. Infect Immun 80, 2667\u20132677 (2012).","journal-title":"Infect Immun"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.molimm.2009.02.021","article-title":"A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups","volume":"46","author":"Beernink PT","year":"2009","unstructured":"PT Beernink, C LoPasso, A Angiolillo, F Felici, D Granoff, A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups. Mol Immunol 46, 1647\u20131653 (2009).","journal-title":"Mol Immunol"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/srep00341","article-title":"A broadly cross-reactive monoclonal antibody against an epitope on the N-terminus of meningococcal fHbp","volume":"2","author":"Vu DM","year":"2012","unstructured":"DM Vu, R Pajon, DC Reason, DM Granoff, A broadly cross-reactive monoclonal antibody against an epitope on the N-terminus of meningococcal fHbp. Sci Rep 2, 341 (2012).","journal-title":"Sci Rep"},{"key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.1003470","article-title":"A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination","volume":"186","author":"Beernink PT","year":"2011","unstructured":"PT Beernink, , A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination. J Immunol 186, 3606\u20133614 (2011).","journal-title":"J Immunol"},{"key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"e01625","DOI":"10.1128\/mBio.01625-14","article-title":"Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding","volume":"5","author":"Costa I","year":"2014","unstructured":"I Costa, R Pajon, DM Granoff, Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding. MBio 5, e01625\u2013e14 (2014).","journal-title":"MBio"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/infdis\/jiv081","article-title":"Binding of complement factor H (FH) decreases protective anti-FH binding protein antibody responses of infant rhesus macaques immunized with a meningococcal serogroup B vaccine","volume":"212","author":"Granoff DM","year":"2015","unstructured":"DM Granoff, , Binding of complement factor H (FH) decreases protective anti-FH binding protein antibody responses of infant rhesus macaques immunized with a meningococcal serogroup B vaccine. J Infect Dis 212, 784\u2013792 (2015).","journal-title":"J Infect Dis"},{"key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"e1002688","DOI":"10.1371\/journal.ppat.1002688","article-title":"The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein","volume":"8","author":"Beernink PT","year":"2012","unstructured":"PT Beernink, , The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein. PLoS Pathog 8, e1002688 (2012).","journal-title":"PLoS Pathog"},{"key":"e_1_3_4_28_2","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature07769","article-title":"Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates","volume":"458","author":"Schneider MC","year":"2009","unstructured":"MC Schneider, , Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature 458, 890\u2013893 (2009).","journal-title":"Nature"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1099\/mic.0.029876-0","article-title":"The modular architecture of meningococcal factor H-binding protein","volume":"155","author":"Beernink PT","year":"2009","unstructured":"PT Beernink, DM Granoff, The modular architecture of meningococcal factor H-binding protein. Microbiology 155, 2873\u20132883 (2009).","journal-title":"Microbiology"},{"key":"e_1_3_4_30_2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CVI.00403-08","article-title":"Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2","volume":"16","author":"Koeberling O","year":"2009","unstructured":"O Koeberling, S Giuntini, A Seubert, DM Granoff, Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2. Clin Vaccine Immunol 16, 156\u2013162 (2009).","journal-title":"Clin Vaccine Immunol"},{"key":"e_1_3_4_31_2","first-page":"571","volume-title":"Protein Identification and Analysis Tools on the ExPASy Server","author":"Gasteiger E","year":"2005","unstructured":"E Gasteiger, Protein Identification and Analysis Tools on the ExPASy Server, ed JM Walker (Humana Press, Clifton, NJ), pp. 571\u2013607 (2005)."},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1107\/S0907444994003112","article-title":"The CCP4 suite: Programs for protein crystallography","volume":"50","author":"Collaborative Computational Project, Number 4","year":"1994","unstructured":"; Collaborative Computational Project, Number 4, The CCP4 suite: Programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50, 760\u2013763 (1994).","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: A comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams PD","year":"2010","unstructured":"PD Adams, , PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley P","year":"2010","unstructured":"P Emsley, B Lohkamp, WG Scott, K Cowtan, Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.4049\/jimmunol.172.9.5606","article-title":"Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine","volume":"172","author":"Welsch JA","year":"2004","unstructured":"JA Welsch, R Rossi, M Comanducci, DM Granoff, Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine. J Immunol 172, 5606\u20135615 (2004).","journal-title":"J Immunol"},{"key":"e_1_3_4_36_2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/infdis\/jit239","article-title":"Importance of inhibition of binding of complement factor H for serum bactericidal antibody responses to meningococcal factor H-binding protein vaccines","volume":"208","author":"Konar M","year":"2013","unstructured":"M Konar, DM Granoff, PT Beernink, Importance of inhibition of binding of complement factor H for serum bactericidal antibody responses to meningococcal factor H-binding protein vaccines. J Infect Dis 208, 627\u2013636 (2013).","journal-title":"J Infect Dis"},{"key":"e_1_3_4_37_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1385\/1-59259-148-5:81","volume-title":"Meningococcal Vaccines: Methods and Protocols","author":"Frasch CE","year":"2001","unstructured":"CE Frasch, L van Alphen, J Holst, JT Poolman, E Rosenqvist, Outer membrane vesicle vaccines for meningococcal disease. Meningococcal Vaccines: Methods and Protocols, eds AJ Pollard, MC Maiden (Humana Press, Totawa, NJ), pp. 81\u201387 (2001)."},{"key":"e_1_3_4_38_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0882-4010(88)90045-9","article-title":"Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA","volume":"4","author":"Abdillahi H","year":"1988","unstructured":"H Abdillahi, JT Poolman, Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA. Microb Pathog 4, 27\u201332 (1988).","journal-title":"Microb Pathog"},{"key":"e_1_3_4_39_2","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1093\/bioinformatics\/btm404","article-title":"Clustal W and Clustal X version 2.0","volume":"23","author":"Larkin MA","year":"2007","unstructured":"MA Larkin, , Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947\u20132948 (2007).","journal-title":"Bioinformatics"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.pnas.org\/syndication\/doi\/10.1073\/pnas.1507829112","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1507829112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T09:21:22Z","timestamp":1654593682000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1507829112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,16]]},"references-count":39,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1073\/pnas.1507829112"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1507829112","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,16]]},"assertion":[{"value":"2015-11-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}